BPC-157 for Heart Health: What the Evidence Shows
What human and animal studies show about BPC-157 for heart health, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Animal
- Human studies
- 3
- PubMed records, our ledger
- Animal studies
- 5
- PubMed records, our ledger
- Studies we summarised
- 1
- with an outcome for heart health
Evidence for heart health
Each row is an outcome related to heart health from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Myocardial infarction markers | BPC 157 reduced cardiac necrosis markers and attenuated gross, histological, ECG and echocardiographic damage in rats given isoprenaline. | Animal · rat (not a human result) | Biomedicines 2022, PMID 35203478 |
PubMed records for BPC-157 and heart health: 3 human, 5 animal (search counts, not studies we reviewed). Grades follow our evidence scale.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Other peptides people research for heart health
All peptides for heart health, comparedCommon questions
Does BPC-157 help with heart health?
The strongest study we summarise for heart health is animal evidence, across 1 study with an outcome for heart health. That is not proof it works in people.
Is BPC-157 approved for heart health?
No. BPC-157 is not FDA approved for any use, including heart health.
What is the best peptide for heart health?
There is no single answer. Our heart health overview compares each candidate by evidence grade and legal status rather than by popularity.
More on BPC-157
Sources
- 1Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats.Biomedicines · 2022PMID 35203478Accessed 2 Oct 2026
Found an error? Report a correction.